Our recent findings on the distinct modulation of cellular activity of telomerase by HMGB1 and HMGB2 [10,17,28] could be a starting point for developing new approaches aiming at the promotion of cell death in drug-treated cancer cells. The gene discussed is HMGB1; the disease is cancer.